IMVT insider trading — Immunovant, Inc.
Over the last 90 days, insiders at Immunovant, Inc. (IMVT) made 0 open-market purchases worth $0 and 8 open-market sales worth $968K, making them net sellers by $968K. The largest sale was by Girao Tiago (Chief Financial Officer), who sold 6,798 shares for $263K on Jul 23, 2026.
Updated Oct 16, 2026.
Recent IMVT insider transactions
Every Form 4 filed by Immunovant, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | Stout Jay S | Chief Technology Officer | S · Sale | Direct | 3,809 | $32.06 | $122K | Form 4 |
| Oct 7, 2026 | Van Tuyl Christopher | Chief Legal Officer | S · Sale | Direct | 1,327 | $32.06 | $43K | Form 4 |
| Oct 7, 2026 | Gloria Melanie | Chief Operating Officer | S · Sale | Direct | 2,241 | $32.06 | $72K | Form 4 |
| Oct 2, 2026 | Venker Eric | Chief Executive Officer | S · Sale | Direct | 3,506 | $34.11 | $120K | Form 4 |
| Oct 1, 2026 | Venker Eric | Chief Executive Officer | M · Option exercise | Direct | 92,187 | $14.46 | $1.33M | Form 4 |
| Oct 1, 2026 | Venker Eric | Chief Executive Officer | D · Disposition | Direct | 85,886 | $33.65 | $2.89M | Form 4 |
| Sep 23, 2026 | Van Tuyl Christopher | Chief Legal Officer | S · Sale | Direct | 2,846 | $36.36 | $103K | Form 4 |
| Aug 28, 2026 | Pande Atul | Director | M · Option exercise · 10b5-1 | Direct | 1,500 | $8.43 | $13K | Form 4 |
| Aug 28, 2026 | Pande Atul | Director | S · Sale · 10b5-1 | Direct | 1,500 | $43.27 | $65K | Form 4 |
| Aug 20, 2026 | Gloria Melanie | Chief Operating Officer | S · Sale | Direct | 3,056 | $44.16 | $135K | Form 4 |
| Jul 24, 2026 | Pande Atul | Director | M · Option exercise · 10b5-1 | Direct | 1,500 | $8.43 | $13K | Form 4 |
| Jul 24, 2026 | Pande Atul | Director | S · Sale · 10b5-1 | Direct | 1,500 | $39.80 | $60K | Form 4 |
| Jul 23, 2026 | Girao Tiago | Chief Financial Officer | S · Sale | Direct | 6,798 | $38.69 | $263K | Form 4 |
| Jul 23, 2026 | Stout Jay S | Chief Technology Officer | S · Sale | Direct | 2,857 | $38.69 | $111K | Form 4 |
IMVT insider trading FAQ
Are insiders buying IMVT stock?
Not on the open market. In the last 90 days, Immunovant, Inc. insiders made no open-market purchases, and 8 open-market sales totaling $968K. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading IMVT?
Recent sellers: Girao Tiago, Gloria Melanie, Stout Jay S, Van Tuyl Christopher, Venker Eric.
Where does IMVT insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.